We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.3B
Cap. Flow %
-2.04%
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$712M
2
META icon
Meta Platforms (Facebook)
META
+$565M
3
PYPL icon
PayPal
PYPL
+$556M
4
MS icon
Morgan Stanley
MS
+$541M
5
PFE icon
Pfizer
PFE
+$388M

Sector Composition

Rank Sector Weight
1 Technology 24.81%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
3151
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$210K ﹤0.01%
61
+1
+2% +$4.3K
SRT
3152
DELISTED
Startek Inc.
SRT
$210K ﹤0.01%
48,181
+1,032
+2% +$4.87K
JBIO
3153
Jade Biosciences
JBIO
$1.34B
$209K ﹤0.01%
409
CYD icon
3154
China Yuchai International
CYD
$1.78B
$209K ﹤0.01%
17,969
-1,068
-6% -$13.8K
SPOK icon
3155
Spok Holdings
SPOK
$241M
$209K ﹤0.01%
25,982
AMPE
3156
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$207K ﹤0.01%
1,606
GLSI icon
3157
Greenwich LifeSciences
GLSI
$211M
$206K ﹤0.01%
9,575
GTBP icon
3158
GT Biopharma
GTBP
$11.5M
$204K ﹤0.01%
2,362
+27
+1% +$2.38K
LEGH icon
3159
Legacy Housing
LEGH
$694M
$204K ﹤0.01%
8,329
SYRS
3160
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$202K ﹤0.01%
18,325
+266
+1% +$4.76K
THRX
3161
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$202K ﹤0.01%
17,494
PPTA
3162
Perpetua Resources
PPTA
$3.09B
$201K ﹤0.01%
43,212
RLYB icon
3163
Rallybio
RLYB
$85.8M
$199K ﹤0.01%
+3,224
New +$267K
TYRA icon
3164
Tyra Biosciences
TYRA
$1.58B
$197K ﹤0.01%
18,400
IMRX icon
3165
Immuneering
IMRX
$292M
$196K ﹤0.01%
27,047
+15,287
+130% +$147K
SMED
3166
DELISTED
Sharps Compliance Corp
SMED
$194K ﹤0.01%
34,605
FORA
3167
DELISTED
Forian
FORA
$188K ﹤0.01%
29,305
DTP
3168
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
0
MBII
3169
DELISTED
Marrone Bio Innovations, Inc.
MBII
$188K ﹤0.01%
166,367
+5,573
+3% +$4.21K
PLSE icon
3170
Pulse Biosciences
PLSE
$2.94B
$186K ﹤0.01%
36,567
EBET
3171
DELISTED
EBET, INC. Common Stock
EBET
$185K ﹤0.01%
811
EPIX
3172
DELISTED
ESSA Pharma
EPIX
$181K ﹤0.01%
29,216
+2,397
+9% +$21.1K
RENT
3173
Rent the Runway
RENT
$124M
$179K ﹤0.01%
1,299
ACLX
3174
DELISTED
Arcellx
ACLX
$178K ﹤0.01%
+12,711
New +$213K
SMMT icon
3175
Summit Therapeutics
SMMT
$11.1B
$178K ﹤0.01%
54,748
-11,295
-17% -$28.5K

Similar funds

Nuveen's Q1 2022 Portfolio in Review

As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
  • Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
  • Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
  • Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
  • Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
  • Nuveen opened 138 new positions and closed 89 in Q1 2022.
  • Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.

Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.